Metabolic Dysfunction-Associated Steatohepatitis (MASH) Study

Now Enrolling Adults Ages 18 to 75

Now Enrolling

About this research study

Metabolic dysfunction-associated steatohepatitis (MASH) is the more serious form of metabolic (dysfunction) associated fatty liver disease (MAFLD) which causes the liver to swell and become damaged. Not all patients with steatosis will progress to MASH and there are currently no clear criteria to identify these patients. There are currently no approved medications for the treatment of MASH.

Velocity is conducting a study for an investigational MASH medication.

Eligible participants...

  • Must be ages 18-75
  • Must have a histological diagnosis of MASH
  • Must NOT have type 1 diabetes
  • Will receive compensation for study-related time
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Huntington Park, California • Velocity Clinical Research

6011 Pacific Blvd, Suite 116, Huntington Park, CA 90255
Phone: (323) 588-1968

Van Nuys, California • Velocity Clinical Research

15211 Vanowen Street, Suite 100, Van Nuys, CA 91405
Phone: (818) 532-6880

Rockville, Maryland • Velocity Clinical Research

1201 Seven Locks Road, Suite 214, Rockville, MD 20854
Phone: (240) 698-2800

Salt Lake City (West Jordan), Utah • Velocity Clinical Research

3590 West 9000 South, Suite 300, West Jordan, UT 84088
Phone: (801) 542-8190

Santa Ana, California • Velocity Clinical Research

2621 South Bristol Street #303, Santa Ana, CA 92704
Phone: (714) 599-8711

Syracuse, New York • Velocity Clinical Research

5000 Brittonfield Parkway, Suite B105, East Syracuse, NY 13057
Phone: (315) 760-5905

Los Angeles (Westlake), California • Velocity Clinical Research

1127 Wilshire Blvd, Suite 805, Los Angeles, CA 90017
Phone: (213) 483-1800

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy